Katherine Cornish-Bowden Purchases 1,500 Shares of International Biotechnology (LON:IBT) Stock

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden bought 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average price of GBX 713 ($8.96) per share, with a total value of £10,695 ($13,446.06).

International Biotechnology Stock Performance

Shares of IBT stock opened at GBX 708 ($8.90) on Thursday. International Biotechnology has a 12 month low of GBX 588 ($7.39) and a 12 month high of GBX 734 ($9.23). The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66. The company has a market cap of £261.68 million, a P/E ratio of 1,475.00 and a beta of 0.21. The firm has a fifty day moving average price of GBX 695.19 and a 200 day moving average price of GBX 678.39.

International Biotechnology Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be given a dividend of GBX 15.56 ($0.20) per share. This is a boost from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 19th. International Biotechnology’s dividend payout ratio is currently 6,041.67%.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.